Haute Capital Partners SA (BX Swiss: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in BioCopy AG (biocopy.com), a Swiss research-based biotechnology company headquartered in Basel, as part of the company’s capital increase.

Haute Capital Partners SA (BX Swiss: HAUTE) announces that Marcel Aellen is stepping down from the Board of Directors to retire, after several years of dedicated service.

Haute Capital Partners SA (BX: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in CARE (care.me), a leading AI-powered preventive health platform headquartered in Switzerland, as part of its Pre Series A 2026 funding round.

Haute Capital maintained a solid balance sheet and continued to expand its asset base in the first half of 2025, despite a more challenging market environment compared to 2024.